1-5 of 5
Burgess B. Freeman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rhabdoid Tumors Are Sensitive to the Protein-Translation Inhibitor Homoharringtonine

Available to Purchase
Thomas P. Howard, Elaine M. Oberlick, Matthew G. Rees, Taylor E. Arnoff, Minh-Tam Pham, Lisa Brenan, Mariana DoCarmo, Andrew L. Hong, Guillaume Kugener, Hsien-Chao Chou, Yiannis Drosos, Kaeli M. Mathias, Pilar Ramos, Brinton Seashore-Ludlow, Andrew O. Giacomelli, Xiaofeng Wang, Burgess B. Freeman, III, Kaley Blankenship, Lauren Hoffmann, Hong L. Tiv, Prafulla C. Gokhale, Cory M. Johannessen, Elizabeth A. Stewart, Stuart L. Schreiber, William C. Hahn, Charles W.M. Roberts
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (18): 4995–5006.
https://doi.org/10.1158/1078-0432.CCR-19-2717
Published: 15 September 2020
View article titled, Rhabdoid Tumors Are Sensitive to the Protein-Translation Inhibitor Homoharringtonine
Open the PDF for Rhabdoid Tumors Are Sensitive to the Protein-Translation Inhibitor Homoharringtonine in another window
Includes: Supplementary data
Journal Articles

Establishing a Preclinical Multidisciplinary Board for Brain Tumors

Free
Birgit V. Nimmervoll, Nidal Boulos, Brandon Bianski, Jason Dapper, Michael DeCuypere, Anang Shelat, Sabrina Terranova, Hope E. Terhune, Amar Gajjar, Yogesh T. Patel, Burgess B. Freeman, Arzu Onar-Thomas, Clinton F. Stewart, Martine F. Roussel, R. Kipling Guy, Thomas E. Merchant, Christopher Calabrese, Karen D. Wright, Richard J. Gilbertson
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (7): 1654–1666.
https://doi.org/10.1158/1078-0432.CCR-17-2168
Published: 02 April 2018
View article titled, Establishing a Preclinical Multidisciplinary Board for Brain Tumors
Open the PDF for Establishing a Preclinical Multidisciplinary Board for Brain Tumors in another window
Includes: Supplementary data
Journal Articles

Population Pharmacokinetics of Bevacizumab in Children with Osteosarcoma: Implications for Dosing

Free
David C. Turner, Fariba Navid, Najat C. Daw, Shenghua Mao, Jianrong Wu, Victor M. Santana, Michael Neel, Bhaskar Rao, Jennifer Reikes Willert, David M. Loeb, K. Elaine Harstead, Stacy L. Throm, Burgess B. Freeman, III, Clinton F. Stewart
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (10): 2783–2792.
https://doi.org/10.1158/1078-0432.CCR-13-2364
Published: 14 May 2014
View article titled, Population Pharmacokinetics of Bevacizumab in Children with Osteosarcoma: Implications for Dosing
Open the PDF for Population Pharmacokinetics of Bevacizumab in Children with Osteosarcoma: Implications for Dosing in another window
Includes: Supplementary data
Journal Articles

Population Pharmacokinetic Analysis of Topotecan in Pediatric Cancer Patients

Free
Paula Schaiquevich, John C. Panetta, Lisa C. Iacono, Burgess B. Freeman, III, Victor M. Santana, Amar Gajjar, Clinton F. Stewart
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (22): 6703–6711.
https://doi.org/10.1158/1078-0432.CCR-07-1376
Published: 15 November 2007
View article titled, Population Pharmacokinetic Analysis of Topotecan in Pediatric Cancer Patients
Open the PDF for Population Pharmacokinetic Analysis of Topotecan in Pediatric Cancer Patients in another window
Includes: Supplementary data
Journal Articles

Evaluation of the Antitumor Efficacy, Pharmacokinetics, and Pharmacodynamics of the Histone Deacetylase Inhibitor Depsipeptide in Childhood Cancer Models In vivo

Free
Claire Graham, Chandra Tucker, Jeremy Creech, Edward Favours, Catherine A. Billups, Tiebin Liu, Maryam Fouladi, Burgess B. Freeman, III, Clinton F. Stewart, Peter J. Houghton
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (1): 223–234.
https://doi.org/10.1158/1078-0432.CCR-05-1225
Published: 05 January 2006
View article titled, Evaluation of the Antitumor Efficacy, Pharmacokinetics, and Pharmacodynamics of the Histone Deacetylase Inhibitor Depsipeptide in Childhood Cancer Models In vivo
Open the PDF for Evaluation of the Antitumor Efficacy, Pharmacokinetics, and Pharmacodynamics of the Histone Deacetylase Inhibitor Depsipeptide in Childhood Cancer Models In vivo in another window